Cure8 regulatory brief
Antibiotics can cause microbiome injury that increases risk of C. difficile and may worsen long-term health issues; identifying ways to protect the gut microbiome during antibiotic use could be especially relevant for people with IBD and other vulnerable groups.
Researchers (microbiome, redox biology), clinicians treating high-risk patients (elderly, immunocompromised, enteral-fed), and patients with IBD/Crohn’s disease interested in microbiome-preserving strategies.
This is a funded, preclinical research project (Brown University) focused on mechanistic and translational work in ex vivo microbiome cultures and mouse models.
The team plans experiments to test whether fiber’s protective effects are mediated by reduced gut eH, to screen non-fiber redox-modulating compounds, and to validate findings in mouse antibiotic-injury models.
If this line of work translates, it could support simple dietary or small-molecule strategies to reduce microbiome disruption during antibiotic therapy — especially for vulnerable groups (elderly, immunocompromised, patients on enteral nutrition, and people with Crohn’s disease).
However, the project is preclinical and does not report human trial results yet.
Project describes preclinical aims using ex vivo cultures and mouse models to test mechanisms and candidate interventions. No human efficacy or safety results are reported.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: National Center for Complementary and Integrative Health - R01AT013053 - $577,136
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Intestinal fibrosis and strictures remain a major cause of surgery and obstruction in Crohn’s disease, and current anti-inflammatory drugs don’t reliably prevent fibrosis. If microbial choline degradation promotes...
Intestinal fibrosis causes strictures that often need surgery and has few effective medical treatments; linking the microbiome to fibrogenesis suggests new prevention or treatment strategies that could reduce surgery...
Environmental pollutants are increasingly linked to Crohn's disease risk, especially when exposures occur in early life. Understanding these links may help explain rising IBD rates and guide future prevention research.
